JF
TERN

Jump Financial’s Terns Pharmaceuticals TERN Stock Holding History

Jump Financial’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13,900
Closed -$38.4K – 2153
2025
Q1 		$38.4K Sell
13,900
-48,501
-78% -$198K ﹤0.01% 1524
2024
Q4 		$346K Buy
62,401
+21,401
+52% +$145K 0.01% 1244
2024
Q3 		$342K Buy
+41,000
New +$337K 0.01% 1251
2023
Q2 		– Sell
-18,356
Closed -$217K – 2154
2023
Q1 		$217K Buy
+18,356
New +$175K 0.01% 1275

Other funds holding TERN

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Jump Financial's TERN Position: Q2 2025 in Review

Jump Financial sold out of Terns Pharmaceuticals (TERN) in Q2 2025, closing a stake of 13,900 shares — an estimated $38.4K sold.

Jump Financial first reported a position in TERN in Q1 2023 and held it in 4 quarters. The position peaked at $346K in Q4 2024. 129 funds tracked by Wall St. Rank hold TERN as of Q2 2025.

  • Jump Financial reported no remaining Terns Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Jump Financial sold 13,900 Terns Pharmaceuticals shares in Q2 2025, an estimated $38.4K.
  • Jump Financial first reported a position in Terns Pharmaceuticals in Q1 2023 and held it in 4 quarters.
  • Jump Financial's Terns Pharmaceuticals position peaked at $346K in Q4 2024.
  • 129 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2025.

Based on Jump Financial's 13F filing for Q2 2025, filed 13 Aug 2025.